SEARCH

SEARCH BY CITATION

References

  • 1
    Martson JA. Report on fever (Malta). Great Britain Army Med Dept Rep 1861; 3: 486521.
  • 2
    Bruce D. Note on the discovery of a micro-organism in Malta Fever. Practitioner 1887; 29: 161.
  • 3
    Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 2003; 16: 6578. 12525425
  • 4
    Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3: 213221. 9204307
  • 5
    Cooper CW. Risk factors in transmission of brucellosis from animals to humans in Saudi Arabia. Trans R Soc Trop Med Hyg 1992; 86: 206209. 1440791
  • 6
    Osoba AO, Balkhy H, Memish Z et al. Diagnostic value of brucella ELISA IgG and IgM in bacteremic and non-bacteremic patients with brucellosis. J Chemother 2001; 13: 5459. AMBIGUOUS 11936381,11434531
  • 7
    Memish Z, Mah MW. Brucellosis in laboratory workers at a Saudi Arabian hospital. Am J Infect Control 2001; 29: 4852. 11172318
  • 8
    al Sekait MA. Seroepidemiological survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med 1999; 19: 219222.
  • 9
    Young EJ, Hall WH. In: Evans AS, Brachman PS. Brucellosis. Bacterial infection of humans: epidemiology and control 3rd edn. 1998 New York Plenum Medical Book Company; 155167.
  • 10
    Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75: 195211. 8699960
  • 11
    Al-Freihi HM, al Mohaya SA, Almohsen MF et al. Brucellosis in Saudi Arabia: diverse manifestation of an important cause of pyrexial illness. Ann Saudi Med 1986; 6: 9597.
  • 12
    Kiel FW, Khan MY. Brucellosis in Saudi Arabia. Soc Sci Med 1989; 29: 9991001. 2814586
  • 13
    Shaalan MA, Memish ZA, Mahmoud SA et al. Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis 2002; 6: 182186. 12718832
  • 14
    Khan MY, Mah M, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis 2001; 32: 11721177. 11283806
  • 15
    Milionis H, Christou L, Elisaf M. Cutaneous manifestations in brucellosis: case report and review of the literature. Infection 2000; 28: 124126. 10782403
  • 16
    Trunnell TN, Waisman M, Trunnell TL. Contact dermatitis caused by Brucella. Cutis 1985; 35: 379381. 3158485
  • 17
    Young EJ. In: Mandell GL, Bennett JE, Dolin R eds.. Brucella species. Mandell, Douglas and Bennett's principles and practice of infectious diseases 4th edn. 1995 New York Churchill Livingstone; 20532060.
  • 18
    Arnow PM, Smaron M, Ormiste V. Brucellosis in a group of travelers to Spain. JAMA 1984; 251: 505507. 6690819
  • 19
    Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990–1998. J Infect Dis 2000; 182: 15031510. 11010841
  • 20
    Bannatyne R, Jackson M, Memish Z. Rapid diagnosis of brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 1997; 35: 26732674. 9316932
  • 21
    Memish Z, Mah MW, Mahmoud S et al. Brucella bacteremia: clinical and laboratory observations in 160 patients. J Infect 2000; 40: 5963. 10762113
  • 22
    Yagupsky P. Detection of Brucella in blood cultures. J Clin Microbiol 1999; 37: 34373442. 10523530
  • 23
    Memish Z, Almuneef M, Mah MW et al. Comparison of brucella standard agglutination test with ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis 2002; 44: 129132. 12458117
  • 24
    Madkour MM. In: Madkour MM eds.. Brucellosis: overview. Brucellosis 2nd edn. 2001 Berlin Springer-Verlag; 114.
  • 25
    Cho HJ, Ingram DG. Mechanisms of prozone formation in agglutination reaction. Can J Microbiol 1972; 18: 449456. 4112241
  • 26
    Griffitts JJ. Agglutination and agglutinin-“blocking” property in serums from known cases of brucellosis. Public Health Rep 1947; 62: 865875.
  • 27
    Hall WH, Manion RE. Comparison of the Coombs test with other methods for Brucella agglutinins in human serum. J Clin Invest 1953; 32: 96106. 13011213
  • 28
    Ariza J, Gudiol F, Pallares R et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin: a randomized, double blind study. Ann Intern Med 1992; 117: 2530. 1596044
  • 29
    Solera J, Rodriguez-Zapata M, Geijo P et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother 1995; 39: 20612067. 8540716
  • 30
    Moreno E. Brucellosis in Central America. Vet Microbiol 2002; 90: 3138. 12414131
  • 31
    Luna-Martinez JE, Mejia-Teran C. Brucellosis in Mexico: current status and trend. Vet Microbiol 2002; 90: 1930. 12414130
  • 32
    Samartino LE. Brucellosis in Argentina. Vet Microbiol 2002; 90: 7180. 12414136
  • 33
    Poester FP, Goncalves VS, Lage AP. Brucellosis in Brazil. Vet Microbiol 2002; 90: 5562. 12414134
  • 34
    Francisco J, Vargas O. Brucellosis in Venezuela. Vet Microbiol 2002; 90: 3944. 12414132
  • 35
    Godfroid J, Kasbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Vet Microbiol 2002; 90: 135145. 12414139
  • 36
    Taleski V, Zerva L, Kantradjiev T et al. An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe. Vet Microbiol 2002; 90: 147155. 12414140
  • 37
    McDermott JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol 2002; 90: 111134. 12414138
  • 38
    Renukaradhya GJ, Isloor S, Rajasekhar M. Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol 2002; 90: 183195. 12414143
  • 39
    Deqiu S, Donglou X, Jiming Y. Epidemiology and control of brucellosis in China. Vet Microbiol 2002; 90: 165182. 12414142
  • 40
    European Commission. Brucellosis in sheep and goats (Brucella Melitensis). SANCO.C.2/AH/R23/2001. 2001 Santa Fe Scientific Committee on Animal Health and Animal Welfare.
  • 41
    Young EJ. In: Steffen R, Lobel HO, Haworth J eds.. Brucellosis in travelers and Brucella that travels. Travel medicine. 1989 New York Springer-Verlag; 375377.
  • 42
    World Health Organization. The development of new improved brucellosis vaccines: report of WHO meeting with the participation of the food and agriculture organization of the United Nations (FAO) and the office international des epizooties (OIE). WHO/EMC/ZDI/98.14. 1997 Geneva WHO.